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D-Lactic acidosis with associated encephalopathy caused by overgrowth of intestinal lactic acid bacteria is a rarely diagnosed
neurological complication of patients with short bowel syndrome. Here, we report the draft genome sequence of Lactobacillus
delbrueckii strain #22 isolated from a patient with short bowel syndrome and previous D-lactic acidosis/encephalopathy.
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In patients with short bowel syndrome (SBS), colonic fermenta-tion of malabsorbed or unabsorbed carbohydrates produces
high amounts of organic acids, such as D-/L-lactic acid and short-
chain fatty acids, resulting in lowered luminal pH. This may pro-
mote the growth of a high concentration of lactic acid bacteria
(LAB), including D-lactic acid-producing bacteria of the genus
Lactobacillus. Additionally, taking antibiotics or probiotics or in-
gesting fermented food (e.g., yogurt, sauerkraut, and pickled veg-
etables) can increase the concentration of these bacteria in the
colon. A high production of D-lactic acid may then occur follow-
ing the ingestion of large amounts of carbohydrates, particularly
readily fermentable simple sugars. D-lactic acidosis occurs because
D-lactic acid can hardly be excreted or metabolized by humans.
Typical clinical symptoms in patients with SBS and D-lactic acido-
sis comprise slurred speech, ataxia, altered mental status, somno-
lence, and even coma (1–5). We have isolated a Lactobacillus del-
brueckii strain, designated L. delbrueckii #22, from a patient with
SBS a few days after an acute episode of D-lactic acidosis and en-
cephalopathy. The in vitro analysis of the culture supernatant of
strain #22 revealed the production of ~98% D-lactic acid and ~2%
L-lactic acid, as determined by the Enzytec D-/L-lactic acid enzy-
matic assay distributed by R-Biopharm AG, Darmstadt, Germany
(6). Written informed consent was obtained from the patient for
the study. The study was approved by the ethics board of the
Justus-Liebig-University of Giessen, Germany (AZ: 192/09).
Lactobacillus spp. are important members of the LAB group
and comprise a large and heterogeneous genus of microaerobic,
catalase-negative, non-spore-forming, Gram-positive rods, which
produce lactic acid as their single or major metabolic end product
from glucose fermentation. Lactobacilli are Janus-faced bacteria
that are generally regarded as safe (GRAS) by the U.S. Food and
Drug Administration (FDA) and are widely used for the produc-
tion of fermented food. Nevertheless, they are able to cause even
severe infections, especially in immunocompromised individuals
(7–9).
DNA sequencing libraries were prepared using the Nextera XT
kit (Illumina, San Diego, CA), according to the manufacturer’s
instructions. Individually tagged libraries were sequenced as a part
of a flow cell on the Illumina MiSeq platform with v2 chemistry
(2 250 bp; Illumina). A total of 6,588,530 paired sequences with
an average length of 134 bp were produced and assembled to 10
contigs, with a total length of 2,188,982 bp, using CLC Genomics
Workbench version 7.0.4. Contigs were ordered to reference
strain L. delbrueckii subsp. bulgaricus ND02 (10) using MAUVE
(11) and annotated by GenDB (12).
The genome analysis revealed three copies of D-lactate dehy-
drogenases and one L-lactate dehydrogenase. This constellation is
a potential explanation for the relative abundance of D-/L-lactic
acid concentration in the bacterial supernatant.
Nucleotide sequence accession number. This whole-genome
shotgun project has been deposited in the European Nucleotide
Archive under the accession no. FLLT01000000. The version de-
scribed in this paper is the first version.
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